MENU
+Compare
ACET
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$0.91
Change
-$0.01 (-1.09%)
Capitalization
74.85M

ACET Adicet Bio Forecast, Technical & Fundamental Analysis

a distributor of pharmaceutical intermediate ingrediants and other industrial chemicals

Industry Biotechnology
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ACET with price predictions
Jan 08, 2025

ACET in downward trend: price may drop because broke its higher Bollinger Band on January 06, 2025

ACET broke above its upper Bollinger Band on January 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 52 similar instances where the stock broke above the upper band. In of the 52 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where ACET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

ACET moved below its 50-day moving average on January 07, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACET entered a downward trend on December 31, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ACET's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 02, 2025. You may want to consider a long position or call options on ACET as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACET just turned positive on December 26, 2024. Looking at past instances where ACET's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ACET advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.354) is normal, around the industry mean (14.744). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). ACET has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.079).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ACET is expected to report earnings to rise 4.21% to -35 cents per share on March 12

Adicet Bio ACET Stock Earnings Reports
Q4'24
Est.
$-0.35
Q3'24
Est.
$-0.34
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.10
Q4'23
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -34 cents, meeting the estimate of -34 cents. With 215.84K shares outstanding, the current market capitalization sits at 74.85M.
A.I.Advisor
published Dividends

ACET paid dividends on October 09, 2018

Adicet Bio ACET Stock Dividends
А quarterly dividend of $0.01 per share was paid with a record date of October 09, 2018, and an ex-dividend date of September 21, 2018. Read more...
A.I. Advisor
published General Information

General Information

a distributor of pharmaceutical intermediate ingrediants and other industrial chemicals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
131 Dartmouth Street
Phone
+1 650 503-9095
Employees
143
Web
https://www.adicetbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALSN119.511.95
+1.66%
Allison Transmission Holdings
MS137.872.06
+1.52%
Morgan Stanley
MGRM2.570.03
+1.18%
Monogram Orthopaedics
SHYF12.420.09
+0.73%
Shyft Group (The)
GNL7.22-0.05
-0.69%
Global Net Lease

ACET and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-1.22%
OGI - ACET
41%
Loosely correlated
-1.27%
DVAX - ACET
39%
Loosely correlated
+0.48%
FATE - ACET
38%
Loosely correlated
+1.60%
CABA - ACET
38%
Loosely correlated
+12.76%
ARWR - ACET
36%
Loosely correlated
+2.84%
More